Vincent Lusco, MD
Surgery · Louisville, KYNPI 1508868753
Payments from drug & device makers
Across 100 payments — averaging $47.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Reshape Lifesciences Inc.$2K
- Davol Inc.$620
- Novo Nordisk$299
- Kerecis Limited$220
- Vertex$204
- TELA Bio, Inc.$194
- plus $2K from 30 others
What the payments were for
- Consulting fees$50011%
- Food & beverage$3,74279%
- Entertainment$49410%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Reshape Lifesciences Inc. | 17 | $1,608 |
| Davol Inc. | 8 | $620 |
| Novo Nordisk | 10 | $299 |
| Kerecis Limited | 4 | $220 |
| Vertex | 4 | $204 |
| TELA Bio, Inc. | 7 | $194 |
| Johnson & Johnson | 4 | $164 |
| Stryker | 1 | $150 |
| Phathom Pharmaceuticals, Inc. | 2 | $141 |
| Organogenesis Inc. | 4 | $127 |
| Acacia Pharma Inc | 1 | $123 |
| Intuitive Surgical | 2 | $110 |
| Integra Lifesciences Corporation | 5 | $109 |
| Pacira Pharmaceuticals Incorporated | 1 | $89 |
| Innovation Technologies Inc | 1 | $66 |
| Acera Surgical, Inc. | 3 | $53 |
| Paratek Pharmaceuticals, Inc. | 3 | $46 |
| Aroa Biosurgery Incorporated | 3 | $43 |
| Smith+Nephew | 2 | $40 |
| Medtronic | 2 | $33 |
| Sanara Medtech Inc. | 1 | $25 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Ambu Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Innocoll Pharmaceuticals Limited | 1 | $22 |
| Baxter Healthcare | 1 | $21 |
| Polynovo North America LLC | 1 | $21 |
| Braintree Laboratories, Inc. | 1 | $20 |
| AbbVie | 1 | $19 |
| W. L. Gore & Associates, Inc. | 1 | $18 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $16 |
| Avanos Medical | 1 | $14 |
| Bioventus LLC | 1 | $14 |
| Melinta Therapeutics, LLC | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Olympus America Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,735 in reported general payments places this provider in the 60th percentile of 377 surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 22 | $489 |
| Pantoprazole Sodium | 26 | $319 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $245 |
| Celecoxib | 14 | $103 |
| Promethazine Hcl | 17 | $29 |
Paid to pharmacies, not to this prescriber.
Other surgery in Louisville
- John OldhamLouisville$515K
- Frank MillerLouisville$119K
- Jared DavisLouisville$89K
- Farid KehdyLouisville$81K
- Timothy DawsonLouisville$63K
- Gary VitaleLouisville$63K
- John OlsofkaLouisville$59K
- Keith MillerLouisville$38K
- Gerald CheadleLouisville$22K
- George MarshallLouisville$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.